Tim Charlebois is a Senior Fellow at NIIMBL and serves as an advisor to biopharma and biotech companies on a consulting basis. He retired from Pfizer after a 30-year career with the company including legacy companies Wyeth and Genetics Institute, where his experience focused on drug substance process development and support for biopharmaceutical products. As VP of Technology & Innovation Strategy for Pfizer Biotherapeutics Pharmaceutical Sciences, he was responsible for building new business processes and a network of leaders across the organization in the areas of technology strategy and platforms, external collaborations and alliances, in- and out-licensing due diligence and business development as well as external disclosure and intellectual property.